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Abstract  
Background: The clinical implications of enlarged early cortical components of 
somatosensory evoked potentials (giant SEPs) in benign adult familial myoclonus 
epilepsy (BAFME) remains unknown. 
Methods: SEPs following electrical stimulation of the median nerve at the wrist were 
studied in 16 patients with a clinical diagnosis of BAFME (7 men and 9 women, mean 
age: 51 ± 18 years) and 19 age-matched apparently healthy control subjects (11 men 
and 8 women, mean age 49 ± 18 years). 
Results: Giant SEPs were observed in 13 of the 16 patients. P25 and N35 amplitudes 
in the patient group were 11.4 ± 6.1 μV and 19.2 ± 11.5 μV, respectively, and both 
were significantly larger compared with those in control subjects (P = 0.008 for P25 
and P < 0.0001 for N35). There was a significant positive relationship between age at 
the SEP examination and N20, P25 and N35 amplitudes both in the patient and 
control groups (P < 0.05). The linear regression gradient of the N35 amplitude with 
respect to age was significantly larger in the patient group than in the control group (P 
= 0.04). Furthermore, regression analysis showed a significant positive relationship 
between the myoclonus rating scale and age at the time of the SEP examination (R = 
0.645, P = 0.007). 
Conclusions: SEP amplitude increased with age in patients with BAFME to a greater 
extent than in the control subjects, which suggests a progressive increase in cortical 
excitability based on a progressive pathophysiology in BAFME. 
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Introduction 
Benign adult familial myoclonus epilepsy (BAFME) is an autosomal 
dominant disease characterized by tremulous myoclonus resembling essential tremor 
and infrequent generalized seizures. BAFME is not currently listed by the 
International League Against Epilepsy, and previous reports cited BAFME as a 
probable epileptic syndrome within the idiopathic generalized epilepsies [1]. The term 
‘benign’ was assigned because of the non-progressive course and rare occurrence of 
generalized convulsions associated with this condition. BAFME has been reported 
from Japan and Europe with various names, including cortical tremor [2], BAFME [3], 
familial cortical myoclonic tremor [4], familial cortical tremor with epilepsy [5], 
familial cortical myoclonic tremor with epilepsy [6] and familial adult myoclonic 
epilepsy [7]. At least as far as the cases reported from Japan are concerned, these 
diverse terms can be suggested to represent the same clinical entity. 
Electrophysiological studies in patients with BAFME disclosed the features of cortical 
reflex myoclonus including excessively enlarged cortical components of 
somatosensory evoked potentials (giant SEPs), an enhanced long loop reflex 
(C-reflex) and the occurrence of cortical spikes preceding myoclonic jerks 
demonstrated by jerk-locked back averaging (JLA) [2, 4]. Giant SEPs are considered 
to represent cortical hyperexcitability of the primary somatosensory cortex in 
response to somatosensory stimuli [8] and to result from pathological enhancement of 
normal SEP components [9, 10]. However, the relationship between the clinical 
profiles of patients and giant SEPs in BAFME remains undetermined. 
In the present study, we aimed at elucidating how giant SEPs are related to 
clinical profiles of patients with BAFME. Since SEPs become larger with aging in 
normal subjects [11], we paid special attention to the effect of aging on giant SEPs. If 
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the giant SEPs also were shown to be larger in aged patients with BAFME, it would 
be worthwhile to clarify whether the enlargement is proportional to the physiological 
enlargement found with normal aging or is related to progressive changes in the 
underlying pathophysiology. 
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Subjects and methods 
Subjects 
Diagnostic criteria for BAFME used in this study were: (a) tremulous 
myoclonus and infrequent generalized seizures appearing after the second decade of 
life, (b) autosomal dominant inheritance, (c) lack of cognitive decline and other 
neurological symptoms, (d) features of cortical reflex myoclonus demonstrated by 
electrophysiological studies, and (e) lack of clear progression apparent through 
clinical observation (i.e., no severe disability in daily life such as walking, feeding, 
speech and intellectual function, except for writing due to cortical tremor). However, 
some patients with either tremulous myoclonus or infrequent generalized seizures 
alone were also included in this study, if (1) at least one electrophysiological 
indication of cortical reflex myoclonus (giant SEPs, C-reflex, or cortical spike 
preceding myoclonic jerks by JLA) was demonstrated and if (2) at least one family 
member had the diagnosis of BAFME, suggestive of autosomal dominant inheritance. 
Sixteen patients (7 men and 9 women) with the clinical diagnosis of BAFME 
who were under care in 3 different hospitals during the last 20 years were studied with 
regard to SEPs. The mean age at the time of SEP recording was 51 ± 18 years (S.D., 
range 27-76 years) (Table 1). Six of these patients (No. 3, 4, 7, 8, 10 and 11) were 
previously reported for different purposes [2, 4]. Among the 16 BAFME patients, 14 
had tremulous myoclonus and 11 had infrequent generalized seizures (Table 1). Two 
patients (Patients 6 and 16) had only equivocal (Patient 6) or transient (Patient 16) 
fine hand tremor. The onset age of tremulous myoclonus was 38 ± 16 (10-70) years 
and that of generalized seizure was 41 ± 19 (17-73) years. Generalized seizure 
occurred after the onset of the tremulous myoclonus except in 1 patient (Patient 10). 
The duration of tremulous myoclonus was 15 ± 13 (2-44) years. The severity of 
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tremulous myoclonus was classified according to the authors’ previous report as 
shown in the supporting material (available online) and Table 1 [12]. Scoring of the 
severity of tremulous myoclonus was retrospectively done by one of the authors (A.I.) 
based on detailed descriptions of neurological findings in patients’ medical charts. 
SEPs were recorded in 19 age-matched apparently healthy control subjects 
(11 men and 8 women, mean age 49 ± 18 years, range 22-74 years) at Kyoto 
University Hospital. The institutional review board of Kyoto University Hospital 
approved performance of SEP recording in control subjects (No. E678). In the 
BAFME patients, SEP studies were done as a part of their clinical evaluation in each 




Scalp SEPs in response to stimulation of the median nerve at the wrist were 
examined in all patients and control subjects. Details of recording conditions are given 
in the supporting material (available online). Nomenclature of the peaks (N20, P25 
and N35) was adopted from the authors’ previous report [10]. Amplitude of P25 and 
N35 was measured from the preceding peak of opposite polarity [10, 11, 13], and that 
of N20 was measured from the pre-stimulus baseline. Since the SEP amplitude was 
shown to increase with age in control subjects [11, 14], the upper limit of the normal 
range of the amplitude was set at the mean + 3 S.D. of values obtained from the 10 
control subjects in the younger subgroup (≤ 50 years old) and 9 control subjects in the 
older subgroup (> 50 years): P25 > 10.0 μV or N35 > 8.1 μV for the younger 
subgroup and P25 > 20.0 μV or N35 > 14.8 μV for the older subgroup. 
 
Hitomi et al 8 
Statistical Analysis  
In order to evaluate the effect of aging on myoclonus, we investigated the  
relationship between the myoclonus rating scale and age at the SEP examination by 
simple linear regression analysis. 
To analyze SEP data, we first compared the latencies and amplitudes of the  
early cortical components (N20, P25 and N35) between electrodes C3/C4 and C3’/C4’ 
in the patient group. Since there was no significant difference either in latency or 
amplitude between these two electrode pairs, the Mann-Whitney U test was used to 
compare the latencies and amplitudes of those 3 peaks in the patient group with data 
obtained from C3’/C4’ in the control group. In the patient group, we investigated the 
relationship between clinical profiles (age at the time of SEP examination, age at 
onset, duration of tremulous myoclonus, and the myoclonus rating scale) and SEP 
parameters by simple linear regression analysis. SEP parameters were also analyzed 
with respect to other clinical factors (gender, presence of seizure, and type of 
anticonvulsant used) by the Mann-Whitney U test. In the control group, simple linear 
regression was used to evaluate the relationship between age at the time of the SEP 
examination and SEP parameters. If there was a significant positive relationship 
between age at the time of the SEP examination and SEP parameters either in the 
patient group or in the control group, the regression gradient between age and SEP 
parameters in the patient group was compared with that in the control group. The level 
of statistical significance was set at P < 0.05.  
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Results  
 
Myoclonus rating scale according to age in patients with BAFME 
Myoclonus was marked and severe in 4 of the aged patients (Patients 3, 4, 11 
and 13), mild in 3 patients (Patients 1, 2, and 14), moderately severe in 7 patients, and 
absent in the remaining 2 patients (Patients 6 and 16) (Table 1). Regression analysis 
showed a significant positive relationship between the myoclonus rating scale and age 
at the time of the SEP examination (R = 0.645, P = 0.007) (Fig. 1).  
 
Scalp SEPs 
In patients with BAFME, there was no significant difference in latencies or 
amplitudes of SEPs between C3/C4 and C3’/C4’. Therefore, we analyzed the SEP 
data on all patients as a “single” group. 
Latencies of SEPs in the patient group were not significantly different from 
those in the control group (Table 2). With regard to amplitudes, P25 and N35 were 
significantly larger in the patient group than in the control group (P = 0.008 for P25 
and P < 0.0001 for N35) (Table 2). In contrast, the N20 amplitude was smaller in the 
patient group than in the control group (P = 0.006). 
According to the definition of giant SEPs adopted in this study, 13 patients 
had giant SEPs (Table 1). In contrast, an enlarged P25 or N35 was not noted in 3 
patients (Patients 2, 4 and 8) although they all 3 had at least one of the 
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Relationship between clinical profiles and SEP parameters 
(a) Patient group 
As for latencies, there was no significant relationship between clinical 
profiles and early cortical components of SEPs (N20, P25 and N35) in BAFME 
patients. With regard to amplitudes, regression analysis showed a significant positive 
relationship between age at the time of the SEP examination and N20 (R = 0.675, P = 
0.0057), P25 (R = 0.689, P = 0.0032) and N35 (R = 0.605, P = 0.013) (Figs. 2A, 2B, 
and 2C). Representative cases from the same pedigree are shown in Fig. 3. A 
58-year-old man (Patient 1) had giant SEPs (Fig. 3A), while his 34-year-old son 
(Patient 2) did not (Fig. 3B). A similar tendency was observed in the other pedigrees 
(Patients 10 and 11, and Patients 14 and 15). Otherwise, there was no significant 
relationship between clinical profiles (onset age, disease duration of tremulous 
myoclonus and the myoclonus rating scale) and SEP amplitudes. There was no 
significant difference in the SEP amplitudes with regard to gender, experience of 
seizure or administration of anticonvulsants. 
 
(b) Control group 
As for the control group, there was also a significant positive relationship 
between age at the time of the SEP examination and N20 (R = 0.49, P = 0.0331), P25 
(R = 0.732, P = 0.0004) and N35 (R = 0.559, P = 0.0004) amplitudes measured at 
C3’/C4’ (Figs. 2A, 2B, and 2C).  
 
(c) Comparison between patient and control groups 
Comparison of the regression gradient for age and SEP amplitudes between 
the two groups showed no significant difference in terms of N20 and P25 amplitudes. 
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The regression for N20 amplitude in the patient group (Y = 0.468 + 0.047 × X) was 
almost the same as that in the control group (Y = 1.967 + 0.048 × X) (Fig. 2A). The 
regression for P25 amplitude in the patient group (Y = －0.308 + 0.233 × X) was 
almost twice as large as that in the control group (Y = －0.156 + 0.139 × X), but the 
difference did not reach statistical significance (Fig. 2B). In contrast, the regression 
gradient of N35 amplitude was significantly higher in the patient group (Y = －0.43 
+ 0.389 × X) than in the control group (Y = －0.702 + 0.089 × X) (P = 0.04) (Fig. 
2C).
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Discussion 
With regard to the diagnostic criteria of BAFME, some patients with 
myoclonus alone [15] and others with generalized seizures alone were also included 
in previous studies of BAFME [16, 17]. These criteria are similar to those in the 
present study. The lack of a seizure history in 2 young patients in the present series 
(Patients 8 and 9) may be due to the rare incidence of seizures in this condition as 
described previously [7]. In genetic investigations of BAFME, the condition in 
Japanese families was linked to chromosome 8q [7, 18] and in European families was 
linked to chromosomes 2p [16, 17, 19] and 5p [20]. However, another report showed 
no linkage to chromosome 8q in some Japanese families [21]. Moreover, a possible 
anticipation was suggested in a Japanese pedigree [22]. Overall, the genetic diagnosis 
of BAFME has not been established and remains unclear. At present, clinical and 
electrophysiological findings and a positive, consistent family history are essential for 
the diagnosis of BAFME. Therefore, our inclusion criteria in the present series are 
considered to be appropriate. Discussion of the relationship between anticonvulsants 
and SEP amplitude is shown in the supporting material (available online). 
The present study demonstrated that the early cortical components of SEPs, 
i.e., P25 and N35, were significantly enlarged in most patients with BAFME. 
Furthermore, both in the patient group and age-matched control group, all 3 peaks 
(N20, P25, and N35) were significantly larger in the aged than in the young subjects. 
Here, it is noteworthy that, among these 3 peaks, only N35, but not the N20 or P25, 
was found to become significantly larger with aging in the patient group than in the 
control group. The physiological mechanisms underlying this discrepancy remain to 
be elucidated, but may be closely related to the mechanisms of myoclonus generation. 
Therefore, it is conceivable that there is an excessive increase in cortical 
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hyperexcitability with aging in this condition, although part of the increased SEP 
amplitude with aging in BAFME might reflect the effect of physiological aging. This 
finding was also supported by the significant increase in the myoclonus rating scale 
with aging in the present study.  
A previous SEP study demonstrated that there was no significant relationship 
between SEP amplitude and age of onset or disease duration of BAFME [15]. 
However, it was also noted that SEP amplitude tended to increase in aged patients 
within the same pedigree. Clinically, only the degree of tremulous myoclonus seemed 
to increase with aging, especially in patients over 70 years of age during a follow-up 
period of 10 to 15 years [7, 23]. On the other hand, Striano et al. reported that giant 
SEPs and enhanced long loop reflex were found in 3 presymptomatic members of a 
BAFME pedigree and that all 3 members developed tremor and myoclonus several 
years later [17]. They postulated that the presence of giant SEPs prior to tremor onset 
might suggest an aberrant integration of somatosensory stimuli that can subsequently 
involve the motor cortex and cause myoclonus. The present findings and those of 
Striano et al. suggest an increase in both tremulous myoclonus and SEP amplitude in 
proportion to aging in patients with BAFME. In other words, cortical 
hyperexcitability develops at a young age and becomes clinically apparent in 
adulthood, and then slightly but significantly increases with further aging. This 
process is so mild that clinical observation may not always be sensitive to delineate 
the chronological evolution of this condition. Our electrophysiological findings may 
serve as a biomarker for the pathological mechanism of BAFME. A prospective SEP 
study along with observation of the clinical course in individual cases of BAFME is 
warranted to confirm this notion.  
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Our findings and those of Striano et al. are also supported by serial 
observation of clinical and neurophysiological findings in Lafora disease, one of the 
progressive myoclonus epilepsies [24]. In that report, a gradual increase was shown in 
SEP amplitude with aging and disease progression, resulting in giant SEPs in Lafora 
disease. However, there was no significant relationship between the myoclonus rating 
scale and SEP amplitude in BAFME in our study, which can probably be explained by 
the relatively small number of examined patients and the simplified myoclonus scale 
(grading according to 5 ranks from 0 to 4). 
In addition, with regard to the terminology of BAFME as it applies at least to 
Japanese patients, it should be discussed whether both “benign” and “adult” are still 
appropriate. More appropriate term for Japanese patients would be discussed in the 
future once similar finding to the present study is confirmed. At the same time, a 
similarly designated study of European patients could be very important to delineate 
the similarity between the two apparently endemic syndromes in Japan and Europe. 
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Figure legends 
 
Figure 1: Results of linear regression between age at the time of examination of 
somatosensory evoked potentials (SEP) and the myoclonus rating scale in 16 
patients with benign adult familial myoclonus epilepsy (BAFME). 
 
There is a significant linear regression between age and the myoclonus rating 
scale in BAFME. 
 
 
Figure 2: Linear regression between age at the time of SEP examination and N20 
(A), P25 (B), and N35 (C) amplitude in 16 patients with BAFME and 19 
age-matched control subjects at C3’/C4’. 
 
Bold black line indicates the simple linear regression curve of patients with 
BAFME and the dotted line indicates that of control subjects. There is a significant 
linear regression between age and N20 amplitude in both groups, but no significant 
difference in the regression gradient between the 2 groups was noted (A). A 
significant linear regression between age and P25 amplitude is evident in both groups, 
but the regression gradient did not differ between groups (B). In both groups, there is 
a significant linear regression between age and N35 amplitude. In addition, there is a 
significant difference between the two groups in the gradient calculated from the 
linear regression line between N35 amplitude and age at the SEP examination (C). 
Abbreviations are defined in the legend for Fig.1. 
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Figure 3: SEP waveform in representative cases from the same pedigree  
 Waveforms of SEPs following right median nerve stimulation in an aged 
patient (Patient 1) (A) and his son (Patient 2) (B). Giant SEPs were found only in 
Patient 1 (A). The abbreviation SEP is defined in the legend for Fig.1. 
Subjects and methods 
 
Myoclonus rating scale 
The severity of tremulous myoclonus was classified according to the authors’ 
previous report as follows: 0: absence of myoclonus, 1: mild myoclonus without 
disturbance of daily activity, 2: moderate myoclonus with some disturbance in daily 
activity, 3: severe myoclonus with clear disturbance in daily activity, and 4: marked 
myoclonus causing incapacity (Table 1) [1]. 
SEP recordings 
SEPs were recorded in a quiet room while the patients and control subjects 
were seated in a reclining chair. During the entire recording period, all subjects were 
kept awake. Electrical stimuli were delivered to the median nerve at the wrist at a fixed 
rate of 1 Hz on average. The stimulus intensity was adjusted to produce a clear twitch of 
the thenar muscle. Scalp electrodes were placed at the contralateral central area; C3 and 
C4 (C3/C4) in 10 patients (Patients 1, 2, 8-13, 15, 16) and C3’ and C4’ (C3’/C4’) (2 cm 
posterior to C3/C4) in 6 patients (Patients 3-7, 14) (Table 1). In control subjects, SEPs 
were recorded both at C3/C4 and C3’/C4’. The electrode impedance was kept below  
5kΩ. The ipsilateral earlobe to the stimulated hand (A1 or A2) was used as the 
reference in 14 patients and all control subjects, and the linked earlobes (A1 + A2) were 
used in 2 patients (Patients 3 and 4). The bandpass filter was set to 1 – 1500 Hz. At least 
200 responses were averaged. Two sets of averages were obtained and reproducibility of 
the SEP waveform was confirmed as shown in Figure 1. We recorded SEPs to bilateral 
median nerve stimulation in all patients and control subjects except 1 patient (Patient 
12) in whom SEPs were recorded to unilateral median nerve stimulation. Thus, we used 
averaged SEP data for right and left median nerve stimulation in most of the patients 
and control subjects. 
Results  
Anticonvulsants 
Anticonvulsants (mainly clonazepam and valproic acid) were used for 
treatment of myoclonus as well as seizures in 9 patients (Patients 2, 5-7 and 11-14 and 
16) (Table 1). Anticonvulsants were administered only after a clinical diagnosis was 
made and SEP recording was done. As a whole, these anticonvulsants including 
phenytoin were judged to have diminished, though not completely abolished, the 





 There was no significant difference in SEP amplitudes related to the use of 
anticonvulsants in the present patients with BAFME, although SEP amplitudes were 
reported to decrease after administration of anticonvulsants in patients with BAFME 
and other cortical reflex myoclonus [2]. Possibly, the negative impact of anticonvulsants 
on SEP amplitudes as opposed to that shown in the previous study could be explained 
by the relatively small number of patients in the present study or differences in 
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 Table  1 Clinical profile of 16 patients with benign adult familial myoclonus epilepsy 
･ * , +, and & indicate the same pedigree  
･ # severity indicates: 0: absence of myoclonus, 1: mild myoclonus without disturbance of daily activity,  
2: moderate myoclonus with some disturbance of daily activity, 3: severe myoclonus with clear disturbance of daily activity 
4: marked myoclonus causing incapacity (Ikeda et al., 1996) 
･ Giant SEP:  P25 > 10.0  μ V or N35 > 8.1  μ V for younger group (50 years or less) and P25 > 20.0  μ 
 
V or N35 > 14.8  μ 
 
V for older group    
(more than 50 years of age). 
･ VPA: valproic acid, CZP: clonazepam, PHT: phenytoin, DZP: diazepam, CBZ: carbamazepine, PB: phenobarbital, TPM: topiramate  
Pt No     Age Sex Recording  Seizure Tremulous myoclonus       Giant  Medication 
electrodes SEP 
Onset age Onset age Severity # 
1 * 58 M C3/C4 – 50 1 + – 
2 * 34 M C3/C4 33 24 1 – VPA, CZP 
3 57 M C3'/C4' 45 40 3 + – 
4 75 M C3'/C4' 73 70 3 – – 
5 50 F C3'/C4' – 45 2 + CZP 
6 31 F C3'/C4' 17 – 0 + VPA 
7 35 M C3'/C4' 30 10 2 + VPA 
8 27 F C3/C4 – 24 2 – – 
9 36 F C3/C4 – 33 2 + – 
10 + 38 M C3/C4 30 35 2 + – 
11 + 74 F C3/C4 – 40 4 + VPA, CZP 
12 69 M C3/C4 35 25 2 + PHT, CZP, DZP 
13 76 F C3/C4 62 59 3 + VPA 
14 & 40 F C3'/C4' 28 20 1 + CZP, CBZ, PB, TPM 
15 & 72 F C3/C4 62 50  2 + – 
16 37 F C3/C4 23 – 0  + VPA 
Table 2 Results of SEP study in BAFME patients and control subjects
•P < 0.05 as compared with control subjects at C3’/C4’ by the Mann–Whitney U test.
Patients with BAFME
(N = 16, age: 51 ± 18 years)
Control subjects
(N = 19, age: 49 ± 18 years) 
Latency (ms)
N20 18.2 ± 1.5 18.5 ± 0.9
P25 23.0 ± 1.6 24.6 ± 2.4
N35 31.6 ± 4.0 30.0 ± 2.0
Amplitude (μV)
N20 2.8 ± 1.2* 4.3 ± 1.8
P25 11.4 ± 6.1* 6.7 ± 3.4
N35 19.2 ± 11.5* 3.7 ± 2.9
 



